Press release
Thalassemia Drugs Market 2024 Share, Trends, Segmentation And Forecast To 2033
Thalassemia Drugs Market Share
Thalassemia Drugs Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $3.4 billion In 2028 At A CAGR Of 10.3%.
The thalassemia drugs market size has grown rapidly in recent years. It will grow from $2.07 billion in 2023 to $2.3 billion in 2024 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to increasing prevalence of thalassemia, genetic predisposition and prevalence, advances in healthcare infrastructure, growing awareness of thalassemia, improvements in diagnostic capabilities.
The thalassemia drugs market size is expected to see rapid growth in the next few years. It will grow to $3.4 billion in 2028 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to growing gene therapies for thalassemia, growing demand for targeted and personalized medicine, increased investments in rare disease drug development, rise in healthcare expenditure, global initiatives for thalassemia awareness. Major trends in the forecast period include personalized treatment regimens, integration of digital health solutions in thalassemia management, development of research on curative therapies, development of combination drug therapies, expansion of patient support programs.
Request A Sample Of This Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=12213&type=smp
Thalassemia Drugs Market Major Segments
The thalassemia drugs market covered in this report is segmented -
1) By Type: Alpha Thalassemia Drugs, Beta Thalassemia Drugs
2) By Treatment Type: Iron Chelation Therapy, Other Treatments
3) By Distribution Channel: Hospital Pharmacies, Online Providers, Drug Stores And Retail Pharmacies
Key Driver - Thalassemia Market Growth Fueled By Increased R&D Expenditure In The Healthcare Sector
Rising R&D expenditure is expected to boost the thalassemia market going forward. R&D investment can be defined as the expenses undertaken by a company for developing, designing, and enhancing its offerings. Increased expenditure can boost innovation and productivity in designing and formulating innovative drugs for the treatment of thalassemia. For instance, according to a report published by the European Federation of Pharmaceutical Industries and Associations, a Belgium-based pharmaceuticals-based trade association, in 2021 European health industries invested about 41.5 billion euros ($44.47 billion) for R&D expenditure, an increase compared to 39.65 billion euros ($42.49 billion) in 2020. Therefore, rising R&D expenditure is driving thalassemia market.
Customise This Report As Per Your Requirements -
https://www.thebusinessresearchcompany.com/Customise?id=12213&type=smp
Prominent Trend - Groundbreaking Cell-Based Gene Therapy For Beta-Thalassemia Treatment
Product innovation is a key trend gaining popularity in the thalassemia drug market. Major companies operating in the thalassemia drug market are developing innovative products to sustain their position in the market. For instance, in August 2022, Bluebird Bio Inc., a US-based biotechnology company, approved Zynteglo (betibeglogene autotemcel) to treat beta-thalassemia. Zynteglo is the first cell-based, one-time gene therapy administered as a single dose. It is prepared by using the patient's genetically modified cells to produce functional beta-globin.
Thalassemia Drugs Market Players
Major companies operating in the thalassemia drugs market report are Pfizer Inc., Merck & Co. Inc., Novartis AG, Sanofi S.A., Fresenius Kabi AG, Bristol Myers Squibb Co., Fresenius SE & Co. KGaA, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Lonza Group AG, Incyte Corporation, Chiesi Farmaceutici S.p.A., Cipla Ltd., Panacea Biotec Ltd., Ionis Pharmaceuticals Inc., Alvogen Inc., Apotex Inc., Acceleron Pharma Inc., Alnylam Pharmaceuticals Inc., Shanghai Bioray Laboratory Inc., La Jolla Pharmaceutical Company, Editas Medicine Inc., Agios Pharmaceuticals Inc., Bluebird Bio Inc., Gamida Cell Ltd., CRISPR Therapeutics AG
View The Full Report Here -
https://www.thebusinessresearchcompany.com/report/thalassemia-drugs-global-market-report
Largest And Fastest Growing Region In The Market
Asia-Pacific was the largest region in the thalassemia drugs market in 2023. The regions covered in the thalassemia drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Thalassemia Drugs Market Report Structure
3. Thalassemia Drugs Market Trends And Strategies
4. Thalassemia Drugs Market - Macro Economic Scenario
5. Thalassemia Drugs Market Size And Growth
…..
27. Thalassemia Drugs Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Thalassemia Drugs Market 2024 Share, Trends, Segmentation And Forecast To 2033 here
News-ID: 3524409 • Views: …
More Releases from The Business research company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Thalassemia
Beta Thalassemia Market Trends, Treatment Landscape, and Growth Opportunities
Introduction
Beta thalassemia is a genetic blood disorder caused by mutations in the beta-globin gene, leading to reduced or absent production of the beta-globin chains of hemoglobin. This results in anemia, fatigue, and a range of complications that can be life-threatening if untreated. The severity of beta thalassemia varies from thalassemia minor, which typically requires no treatment, to thalassemia major (Cooley's anemia), which can lead to severe symptoms and require frequent…
Global Thalassemia Market Size – Forecast to 2026
The findings reviewed by GME stated that the Global Thalassemia Market will expand with a CAGR value of 10.2 percent from 2021 to 2026. Several drivers are likely to accelerate the thalassemia market further, including an increasing occurrence of thalassemia, growing public awareness, expanding expenditure in research & development, and the growing need for improved curative gene therapy.
Browse 159 Market Data Tables and 119 Figures spread through 189 Pages and…
Thalassemia Market to witness steady growth increase by 2024
Zion Market Research analysts forecast the latest report on "Thalassemia Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016-2024", according to their latest report the Thalassemia Market report covers the overall and all-inclusive analysis of the Thalassemia Market with all its factors that have an impact on market growth. The Thalassemia Market's complete outline is crystal clear penned down in the global Thalassemia Market research report such that…
Thalassemia Treatment Market is driven by increase in number of altered thalasse …
Thalassemia Treatment Market - Snapshot
The global thalassemia treatment market is driven by increase in number of altered thalassemia genes across the globe. The global market was valued at US$ 842.0 Mn in 2017 and is projected to expand at a CAGR of 7.9% from 2018 to 2026 to reach US$ 1,639.6 Mn by 2026. The global market is witnessing high growth owing to increase in blood transfusion and chelation therapy…
Thalassemia - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Thalassemia - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thalassemia - Pipeline Review, H1 2017, provides an overview of the Thalassemia (Hematological Disorders) pipeline landscape.
Thalassemia is a group of inherited blood disorders that affect the body's ability to produce hemoglobin and red blood cells. Symptoms…
Global Thalassemia Market Report: 2016 Edition
Thalassemia is a hereditary blood disorder in which a person’s body makes an abnormal form of hemoglobin, which is the protein molecule in red blood cells (RBCs), which carries oxygen. The disorder results in unwarranted damage of red blood cells, which leads to anemia. Anemia is a condition in which the body doesn’t have adequate amount of normal and healthy red blood cells. There are majorly two types of thalassemia…
